Production (Stage)
Sionna Therapeutics, Inc.
SION
$19.94
-$0.49-2.40%
NASDAQ
| 03/31/2025 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 82.78% | 0.00% | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 16.18% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 81.25% | -- | |||
|
|
|||||
| Total Current Assets | 81.25% | -- | |||
| Net Property, Plant & Equipment | -2.80% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | -75.68% | -- | |||
| Total Assets | 99.01% | -- | |||
|
|
|||||
| Total Accounts Payable | 323.19% | -- | |||
| Total Accrued Expenses | -56.32% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 4.38% | -- | |||
| Total Finance Division Other Current Liabilities | -92.07% | -- | |||
| Total Other Current Liabilities | -92.07% | -- | |||
| Total Current Liabilities | -8.57% | -- | |||
|
|
|||||
| Total Current Liabilities | -8.57% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -3.45% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | -6.24% | -- | |||
|
|
|||||
| Common Stock & APIC | 3,128.67% | -- | |||
| Retained Earnings | -9.10% | -- | |||
| Treasury Stock & Other | -18.21% | -- | |||
| Total Common Equity | 314.87% | 0.00% | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 0.00% | |||
|
|
|||||
| Total Common Equity | 314.87% | 0.00% | |||
| Total Preferred Equity | -- | 0.00% | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 111.08% | 0.00% | |||
|
|
|||||